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A simple, precise and economical spectrophotometric method for the 
estimation of Itopride hydrochloride in pharmaceutical bulk and tablet dosage 
form was developed and validated. Identification was carried out using a UV-
visible double beam spectrophotometer detector with working wavelength at 
258nm in 0.1N HCl medium. The method was validated with respect to its 
specificity, linearity range, accuracy, and precision in analytical media. 
Itopride hydrochloride show the maximum absorbance (λmax) at 258 nm, 
Regression analysis showed good correlation in the concentration range 5-
100 mcg/ml and 96.80 to 106.84% recovery with relative standard deviation 
0.293 to 3.98%. Statistical treatment of data reflects that the proposed method 
is precise, accurate and easily applicable for determination of Itopride 
hydrochloride in bulk and pharmaceutical preparation.   
 




Itopride hydrochloride, a novel prokinetic agent has 
been introduced in the Indian market a few months 
back. Itopride has anticholinesterase (AchE) activity 
as well as dopamine D2 receptor antagonistic activity 
and is being used for the symptomatic treatment of 
various gastrointestinal motility disorders.  
On oral administration, Itopride is rapidly and 
extensively absorbed and peak serum concentrations 
are achieved within 35 minutes after oral dosing [1]. 
Food does not affect its absorption [2]. Itopride is 
metabolized in the liver by N-oxidation to inactive 
metabolites by the enzyme flavin-containing 
monooxygenase (FMO).The half life of Itopride is 
about 6 hours. It is excreted mainly by the kidneys as 




A number of analytical methods for quantitative 
estimation of Itopride hydrochloride in 
pharmaceutical products are known. Procedures based 
on LC-MS [4], RP-HPLC [5], spectrofluorimetry, and 
Spectrophotometry [6] is to be found in literature. 
Though these methods are sensitive, they require 
expensive instruments and trained personnel. Despite 
the availability of sophisticated and sensitive 
instruments, for routine quantitative analysis, a simple 
and cost effective analytical method is always 
preferred. In present work, a simple precise, accurate 
and economical UV-spectrophotometric method for 
the estimation of Itopride hydrochloride has been 
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Analytical method development of Itopride 
Hydrochloride 
Development and validation of spectrophotometric 
method 
Different media were investigated to develop a 
suitable UV- spectrophotometric method for the 
analysis of Itopride hydrochloride. For selection of 
media, the criteria employed was sensitivity of the 
method, ease of sample preparation, solubility of the 




Stock solution of 100 mcg/ml (100 ppm) of Itopride 
hydrochloride was prepared in 0.1N HCl (pH-1.4). 
Aliquots of stock solution were transferred into a 
series of precalibrated 100 ml Vol. flask and volume 
was made with the analytical media to make different 
concentrations in the range of 5-100 mcg/ml (5-
100ppm). 
 
Analytical validation [7] 
Specificity and selectivity 
Itopride hydrochloride solution 10 and 20 mcg/ml 
was prepared in selected media along with and 
without common excipients (Lactose, Carbopol 71, 
SCMC, POE, DCP-anhydrous, Talc and Magnesium 
stearate). All solution were scanned in UV range at 
slow speed and observed for change in absorbance 
and percent recovery was estimated. 
 
Accuracy 
As a part of determining accuracy of the proposed 
method different levels of drug concentrations (LQC, 
MQC, HQC in 0.1N HCl) were prepared from 
independent stock solution and analyzed (n=3). 
Accuracy was assessed as percentage relative error 
and mean percentage recovery (Table 3) .To give 
additional support to accuracy of the developed assay 
method, standard addition method was done. In this 
study, different concentrations of pure drug (5, 10 and 
20 mcg in 0.1N HCl) were added to a known 
preanalyzed formulation sample and the total 
concentration was determined using the proposed 
method (n =3). The percent recovery of the added 
pure drug was calculated as: 
 
% Recovery = [(Cv-Cu)/Ca] 100, 
Where, Cv is the total drug concentration measured 
after standard addition; Cu, drug concentration in the 
formulation; Ca, drug concentration added to the 
formulation. 
 
Table 1. Calibration data of the developed method 
(n=9). 
 
Conc.(mcg/ml) Absorbancea % RSDb 
5 0.208  ± 0.0055 2.58 
10 0.392  ± 0.0110 2.73 
15 0.603  ± 0.0190 3.22 
20 0.789  ± 0.0158 6.22 
25 1.007  ± 0.0520 5.16 
30 1.200  ± 0.0513 4.27 
35 1.358  ± 0.0488 3.59 
40 1.518  ± 0.0280 1.84 
50 1.886  ± 0.0686 3.63 
60 2.283  ± 0.0774 4.10 
70 2.647  ± 0.0540 2.04 
80 3.053  ± 0.0122 0.39 
90 3.475  ± 0.0482 1.35 
100 3.789  ± 0.0097 0.25 
 
a = Standard déviation, b = relative standard déviation 
 
Precision 
Inter-day and intra-day variations were taken to 
determine intermediate precision of the proposed 
method. Different levels of drug concentration in 
triplicate were prepared three different times in a day 
and studied for intra-day variation (n=9). Same 
protocol was followed for 3 different days to study 
inter-day variation (n=27). The relative standard 
deviation of the predicted concentrations from the 
regression equation was taken as precision. 
 
Linearity  
To establish linearity of the proposed method, 
fourteen separate series of solution of drug (5-100 
mcg/ml) in 0.1N HCl were prepared from stock 
solution and analyzed. Least square regression 
analysis was done for the obtained data and ANOVA 
test (one way) performed based on the absorbance 
values observed for each pure drug concentration 
during the replicate measurement of the standard 
solution. 
 
Detection and quantitation limit (DL and QL) 
The DL and QL of Itopride hydrochloride by the 
proposed method was determined using calibration 
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standards. DL and QL were calculated as 3.3σ/S and 
10σ/S, respectively, where S is the slope of 
calibration curve and ‘σ’ is standard deviation of y-
intercept of regression equation. 
 
Table 2. Regression and validation parameters of 
Itopride hydrochloride. 
 
Parameters 0.1 N HCl 
Regression parameters  
Slope 0.0337 
Standard error of slopea 0.00015 
95% confidence intervals of slope 0.00372; 0.00377 
Intercept 0.0309 
Standard error of intercepta 0.01633 
95% confidence intervals of intercept 0.0173;0.0309 
Regression correlation coefficient (r) 0.9994 
Validation parameters  
Linearity (mcg/ml) 5-100 
DL (mcg/ml) 0.8735 
QL (mcg/ml) 2.625 
Robustness (mean % recovery ±S.D) 99.065± 0.0023 
 
Robustness 
Changing ionic strength of the media and determining 
stability of Itopride hydrochloride in selected medium 
at different storage condition for 72 hrs determined 
robustness. Series of solution of Itopride 
hydrochloride (20 mcg/ml) were prepared in media 
with different ionic strength (n =3) and mean % 
recovery was determined.  
 
Estimation from Formulation 
Twenty tablets were weighed and pulverized. Amount 
of powder equivalent to 10 mg of drug was taken and 
extracted with 0.1N HCl .The solution was diluted 
suitably to prepare a 100mcg/ml concentration in 
media. Finally solution was filtered through Whatman 
filter paper no.2; filtrate was suitably diluted to 
prepare 20 mcg/ml concentration and analyzed using 
proposed method. 
 
Result and discussion 
Calibration curve 
In 0.1N HCl, absorbance was measured at 258 nm 
with a regression coefficient of 0.999. Calibration 
parameters are listed in (Table 1). The linear 
regression equation obtained was: absorbance at 258 
nm = [0.0374 x concentration in mcg/ml] + 0.0309 
and regression parameters are shown in (Table 2). 
 
Table 3. Recovery of Itopride hydrochloride (20 
mcg/ml) in presence of excipients. 
 
Excipients (150mg) % Recovery 
Lactose 95.25 
Dicalcium phosphate(DCP) 96.31 
Carbopol 71G 97.60 
Polyoxyethylene(POE) 96.57 
Sodium CMC 97.60 
Talc 98.31 
Mg. stearate 98.23 
 
Analytical validation 
Specificity and selectivity 
The UV Spectrum of Itopride hydrochloride was not 
changed in presence of common excipients in the 
selected media. The percentage recovery of drug 
obtained in presence of excipients were closer to 
100% indicating least interference of the excipients 
(Table 3). 
 
Table 4. Accuracy and precision data for the developed method. 
 






Accuracy b % Mean Recovery 
Inter-day(n=27) 
LQC 5 4.949 ± 0.0037 1.80 -1.02 98.98 
MQC 25 26.96± 0.041 3.98 7.8 107.84 
HQC 50 49.53 ± 0.0055 0.293 -0.94 99.06 
Intra-day (n=9) 
LQC 5 4.842 ± 0.0049 2.437 -3.2 96.80 
MQC 25 26.15 ±0.0080 0.801 -1.12 98.88 
HQC 50 49.44 ±0.0091 0.486 4.6 104.6 
 
a- predicted conc. of Itopride hydrochloride was calculated using linear regression equation 
b- Accuracy is given in relative % error =100[(predicted conc.-nominal conc.)/nominal conc.] 
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Accuracy ranged from -3.2% to 4.6% for intra-day 
results and from – 1.02% to 7.8% for inter-day results 
in the selected media. The excellent mean % recovery 
values (nearly 100%) represent accuracy (Table 4). 
The validity and reliability of the proposed method 
was evaluated by recovery studies using standard 
addition method (Table 5). 
 













10 5 15.09 104.8 
10 25 35.25 101.0 
10 50 59.94 99.98 
 
Estimation of formulation 
In the selected medium the assay values for different 
formulation of Itopride hydrochloride ranged from 
98.81 to 99.54 with S.D. not more than 1.34 %. 
 
Table 6. Influence of ionic strength of HCl solution 
on Itopride hydrochloride (10mcg/ml). 
 




0.5 97.90 ±0.0030 
0.25 98.96 ±0.0050 
0.1 100.2 ±0.0015 
0.05 99.2 ±0.0060 
 
Conclusion 
The proposed method of analysis is simple and rapid 
and can be used for routine analysis of Itopride 
hydrochloride in bulk and pharmaceutical 
formulations. 
 
Table 7. Application of spectrophotometric 
method to the determination of Itopride 
hydrochloride in Mktd. Dosage form (n=5). 
 




Mktd. Tablets I-150mg 149.32mg 99.54 








The sample recovery in both the formulation were in 
good agreement with their label claims and thus 
suggested non-interference of formulation excipients 
in estimation and at the same time use of organic 
solvent for extraction of Itopride hydrochloride from 
formulation was avoided. The recommended 
procedure is well suited for the assay and evaluation 
of drugs in pharmaceutical preparations to assure high 
standards of quality control. 
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